China’s Innovent Biologics signs US$10.5 billion Pfizer deal for 12 cancer drug trials
AdvertisementBiomedicine: CompaniesBusinessChina Business China’s Innovent Biologics signs US$10.5 billion Pfizer deal for 12 cancer drug trials The agreement covers eight…